Welcome to the new Gustave Roussy website
A new website designed to offer you a simpler, clearer, and more intuitive experience. Patients, caregivers, healthcare professionals, and donors: find information, news, and services more easily.
Gustave Roussy Prize 2027: Call for Applications Now Open
Building on the success of its first two editions, the Gustave Roussy Prize, which recognizes a researcher whose discoveries have had a major impact on the care of patients living with cancer, will be held again in 2027. Applications are open until August 26, 2026, at 4:00 p.m. CEST. Endowed with €200,000, this prestigious prize will be awarded on February 4, 2027, on the occasion of World Cancer Day.
Published on
Building on the success of its first two editions, the Gustave Roussy Prize, which recognizes a researcher whose discoveries have had a major impact on the care of patients living with cancer, will be held again in 2027. Applications are open until August 26, 2026, at 4:00 p.m. CEST. Endowed with €200,000, this prestigious prize will be awarded on February 4, 2027, on the occasion of World Cancer Day.
Established in 2025, the Gustave Roussy Prize is awarded each year to a leading figure in oncology research whose scientific discoveries in the fields of diagnosis, treatment, or prevention of cancer have significantly improved patient care or contributed to a better understanding of the disease.
The Gustave Roussy Prize highlights innovation and scientific commitment for a tangible and lasting benefit to patients, in full alignment with Gustave Roussy’s mission: to cure more patients, more effectively and sustainably.
With an endowment of €200,000, the Gustave Roussy Prize is among the most generously funded awards worldwide in the field of cancer research.
► Apply before August 26, 2026, at 4:00 p.m. CEST
Researchers of all nationalities and affiliations are invited to submit their application before August 26, 2026, at 4:00 p.m. CEST via the online application form.
Applications will be reviewed by an independent jury of international experts, based on criteria of scientific excellence and clinical impact, without distinction of discipline or institutional affiliation.
The Gustave Roussy Prize is awarded annually by Fondation Gustave Roussy, with the generous support of Laboratoires Pierre Fabre, founding sponsor.
► More information about Gustave Roussy Prize
Last news
-
Breast Cancer: Gustave Roussy Ranked No. 1 in France for Breast Surgery and Breast Reconstruction
On the occasion of Breast Cancer Awareness Month, the 2025 data from Visuchir, the national surgical activity monitoring tool of the French Health Insurance system, places Gustave Roussy in first position for both breast surgery and breast reconstruction. Beyond this ranking, these figures highlight that reconstruction is now an integral part of breast cancer treatment. It is considered at every stage of care: from tumor removal surgery, whether lumpectomy or mastectomy, through to the post-cancer period, helping to restore the body and support women in regaining their physical integrity and quality of life.
-
Newsweek Ranking: Gustave Roussy Named Europe’s Leading Cancer Centre and Third Best Worldwide
The 2027 edition of Newsweek’s World's Best Specialized Hospitals ranking once again recognises Gustave Roussy as the leading cancer centre in France and Europe, and the third best worldwide. This distinction highlights the excellence of the Institute’s care and research, as well as the daily commitment of all its professionals.
-
Living with and beyond cancer: the promises and challenges of digital health
In a Viewpoint article published in The Lancet Digital Health, Drs Ines Vaz-Luis and Maria Alice Franzoi, together with Emmanuel Mussault, a patient partner at the PRISM University Hospital Institute, examine the role that digital tools can play in supporting people living with and beyond cancer. Their central message is that these technologies can support more personalised and accessible care, but their value depends primarily on how they are integrated into care pathways, the human support provided, their ability to address individual needs and their evaluation in real-world settings.
-
Gustave Roussy and The Lancet launch an international lecture series on innovations transforming cancer care
The inaugural lecture in the “Lecture Series on Cancer Breakthroughs” will take place on Friday 18 September at 5:00 pm. It will be delivered by Professor Timothy R. Rebbeck, a leading cancer prevention specialist at Harvard University and the Dana-Farber Cancer Institute.
